Biosimilar Lucentis Sponsors Had To Navigate Different FDA, EMA Requirements

 
• By Sue Sutter
  
Drug Review Profile: Lucentis biosimilars
Biosimillar sponsors had to navigate the different preferences of the US and European regulators. • Source: Shutterstock/Alamy

More from Drug Review Profiles

More from Product Reviews